跳至主要内容
临床试验/NCT02313467
NCT02313467已完成不适用

Topical Application of 1.5% Butenyl ALA Without Light Source Irradiation in the Treatment of Acne: a Double Blinded Randomized Controlled Trial.

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
1
主要终点
Percent change of inflammatory acne lesions compared with baseline

研究概览

简要总结

In this study, the investigators are going to compare the clinical effect and safety of topical application of 1.5% Butenyl ALA cream formula without light source irradiation in the treatment of acne.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • mild to moderate acne vulgaris (Leeds revised acne grading system score 2-7) at baseline.

排除标准

  • known pregnancy
  • lactation
  • any medical illness that might influence the results of the study
  • a history of oral acne medication or surgical procedure, including laser treatment, within 6 months of study enrollment
  • use of topical acne medication within 4 weeks of study enrollment.

研究组 & 干预措施

1.5% Butenyl ALA

Active Comparator

Topical application of 1.5% Butenyl ALA per every other day around acne lesions in the face

干预措施: Topical application of 1.5% Butenyl ALA (Drug)

Control

Sham Comparator

Topical application of sham control per every other day around acne lesions in the face

干预措施: Topical application of sham control (Drug)

结局指标

主要结局

Percent change of inflammatory acne lesions compared with baseline

时间窗: 12 week

次要结局

  • Percent change of non-inflammatory acne lesions compared with baseline(12 week)
  • Percent change of overall severity of acne lesions compared with baseline(12 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dae Hun Suh

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验